The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma

Figure 4

Adjusted Cox regression analysis for subgroups analysis before PSM, adjusted for age, ALT, AST, HB, PLT, LYM, NEU, size, gender, HBV, APF, TACE session, tumor number, cirrhosis, and ECOG. (a) Subgroups analysis for OS. (b) Subgroup analysis for PFS.

(a)

(b)